Micro-RNA Sequencing and Assay - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510240904

Publication Date:

October 1, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and isoforms of miRNAs, and to discover previously uncharacterized miRNAs. Evidence that dysregulated miRNAs play a role in diseases such as cancer has positioned miRNA-seq to potentially become an important tool in the future for diagnostics and prognostics as costs continue to decrease.Like other miRNA profiling technologies, miRNA-Seq has both advantages (sequence-independence, coverage) and disadvantages (high cost, infrastructure requirements, run length, and potential artifacts).
The global market for Micro-RNA Sequencing and Assay was estimated to be worth US$ 231 million in 2023 and is forecast to a readjusted size of US$ 429.3 million by 2030 with a CAGR of 9.8% during the forecast period 2024-2030
North American market for Micro-RNA Sequencing and Assay was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Micro-RNA Sequencing and Assay was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Micro-RNA Sequencing and Assay was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Micro-RNA Sequencing and Assay include Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio and NEB, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Micro-RNA Sequencing and Assay, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Micro-RNA Sequencing and Assay by region & country, by Type, and by Application.
The Micro-RNA Sequencing and Assay market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Micro-RNA Sequencing and Assay.
Market Segmentation
By Company
Illumina
Thermo Fisher Scientific
QIAGEN
Takara Bio
NEB
Segment by Type:
Sequencing by Synthesis
Sequencing by Nanopore
Ion Semiconductor Sequencing
Segment by Application
Research Institute
Academia
CRO
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Micro-RNA Sequencing and Assay manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Micro-RNA Sequencing and Assay in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Micro-RNA Sequencing and Assay in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Micro-RNA Sequencing and Assay Product Introduction
1.2 Global Micro-RNA Sequencing and Assay Market Size Forecast
1.3 Micro-RNA Sequencing and Assay Market Trends & Drivers
1.3.1 Micro-RNA Sequencing and Assay Industry Trends
1.3.2 Micro-RNA Sequencing and Assay Market Drivers & Opportunity
1.3.3 Micro-RNA Sequencing and Assay Market Challenges
1.3.4 Micro-RNA Sequencing and Assay Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Micro-RNA Sequencing and Assay Players Revenue Ranking (2023)
2.2 Global Micro-RNA Sequencing and Assay Revenue by Company (2019-2024)
2.3 Key Companies Micro-RNA Sequencing and Assay Manufacturing Base Distribution and Headquarters
2.4 Key Companies Micro-RNA Sequencing and Assay Product Offered
2.5 Key Companies Time to Begin Mass Production of Micro-RNA Sequencing and Assay
2.6 Micro-RNA Sequencing and Assay Market Competitive Analysis
2.6.1 Micro-RNA Sequencing and Assay Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Micro-RNA Sequencing and Assay Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Micro-RNA Sequencing and Assay as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sequencing by Synthesis
3.1.2 Sequencing by Nanopore
3.1.3 Ion Semiconductor Sequencing
3.2 Global Micro-RNA Sequencing and Assay Sales Value by Type
3.2.1 Global Micro-RNA Sequencing and Assay Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Micro-RNA Sequencing and Assay Sales Value, by Type (2019-2030)
3.2.3 Global Micro-RNA Sequencing and Assay Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Institute
4.1.2 Academia
4.1.3 CRO
4.2 Global Micro-RNA Sequencing and Assay Sales Value by Application
4.2.1 Global Micro-RNA Sequencing and Assay Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Micro-RNA Sequencing and Assay Sales Value, by Application (2019-2030)
4.2.3 Global Micro-RNA Sequencing and Assay Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Micro-RNA Sequencing and Assay Sales Value by Region
5.1.1 Global Micro-RNA Sequencing and Assay Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Micro-RNA Sequencing and Assay Sales Value by Region (2019-2024)
5.1.3 Global Micro-RNA Sequencing and Assay Sales Value by Region (2025-2030)
5.1.4 Global Micro-RNA Sequencing and Assay Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Micro-RNA Sequencing and Assay Sales Value, 2019-2030
5.2.2 North America Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Micro-RNA Sequencing and Assay Sales Value, 2019-2030
5.3.2 Europe Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Micro-RNA Sequencing and Assay Sales Value, 2019-2030
5.4.2 Asia Pacific Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Micro-RNA Sequencing and Assay Sales Value, 2019-2030
5.5.2 South America Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Micro-RNA Sequencing and Assay Sales Value, 2019-2030
5.6.2 Middle East & Africa Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Micro-RNA Sequencing and Assay Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Micro-RNA Sequencing and Assay Sales Value
6.3 United States
6.3.1 United States Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.3.2 United States Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.4.2 Europe Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.5.2 China Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.5.3 China Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.6.2 Japan Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.7.2 South Korea Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.8.2 Southeast Asia Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.9.2 India Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.9.3 India Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Illumina
7.1.1 Illumina Profile
7.1.2 Illumina Main Business
7.1.3 Illumina Micro-RNA Sequencing and Assay Products, Services and Solutions
7.1.4 Illumina Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2019-2024)
7.1.5 Illumina Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific Micro-RNA Sequencing and Assay Products, Services and Solutions
7.2.4 Thermo Fisher Scientific Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 QIAGEN
7.3.1 QIAGEN Profile
7.3.2 QIAGEN Main Business
7.3.3 QIAGEN Micro-RNA Sequencing and Assay Products, Services and Solutions
7.3.4 QIAGEN Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2019-2024)
7.3.5 Takara Bio Recent Developments
7.4 Takara Bio
7.4.1 Takara Bio Profile
7.4.2 Takara Bio Main Business
7.4.3 Takara Bio Micro-RNA Sequencing and Assay Products, Services and Solutions
7.4.4 Takara Bio Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2019-2024)
7.4.5 Takara Bio Recent Developments
7.5 NEB
7.5.1 NEB Profile
7.5.2 NEB Main Business
7.5.3 NEB Micro-RNA Sequencing and Assay Products, Services and Solutions
7.5.4 NEB Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2019-2024)
7.5.5 NEB Recent Developments
8 Industry Chain Analysis
8.1 Micro-RNA Sequencing and Assay Industrial Chain
8.2 Micro-RNA Sequencing and Assay Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Micro-RNA Sequencing and Assay Sales Model
8.5.2 Sales Channel
8.5.3 Micro-RNA Sequencing and Assay Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Illumina
Thermo Fisher Scientific
QIAGEN
Takara Bio
NEB

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂